Discordant proliferation and differentiation in pituitary tumor-transforming gene-null bone marrow stem cells

被引:13
|
作者
Rubinek, Tami
Chesnokova, Vera
Wolf, Ido
Wawrowsky, Kolja
Vlotides, George
Melmed, Shlomo
机构
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Res Inst, Dept Med, Los Angeles, CA USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2007年 / 293卷 / 03期
关键词
securin; cell cycle; hypoplasia;
D O I
10.1152/ajpcell.00145.2007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The mammalian securin, pituitary tumor-transforming gene (Pttg), regulates sister chromatid separation during mitosis. Mice deficient in Pttg expression exhibit organ-specific hypoplasia of the testis, spleen, pituitary, and postmaturity pancreatic beta-cells, pointing to a possible adult stem cell defect. Bone marrow stem cells (BMSCs) contribute to bone, cartilage, and fat tissue repair and regeneration, and multipotent adult progenitor cells (MAPCs) have broader differentiation ability. Bone marrow cells derived under MAPC conditions are involved in a spectrum of tissue repair. We therefore tested whether Pttg deletion affects stem cell proliferation and differentiation. BMSCs were isolated under MAPC conditions, although unlike MAPCs, wild-type (WT) and Pttg(-/-) BMSCs do not express octamer-binding transcription factor 4 and are stem cell antigen-I positive. WT and Pttg(-/-) cells did not differ in their ability to differentiate into adipogenic, osteogenic, or hepatocyte-like cells or in phenotypic markers. Cells underwent > 100 population doublings, with no observed transforming events. Pttg-null BMSCs replicated 27% slower than WT BMSCs, and under hypoxic conditions, this difference widened. Although apoptosis was not enhanced in Pttg(-/-) cells, Pttg(-/-) BMSC senescence-associated beta-galactosidase activity was elevated, consistent with enhanced p21 protein levels. Using gene array assays, DNA repair genes were shown to be upregulated in Pttg(-/-) BMSCs, whereas genes involved in cell cycle progression, including cyclin D-1, were decreased. Separase, the protease regulated by Pttg, has been implicated in DNA damage repair and was downregulated in Pttg(-/-) BMSCs. Separase was constitutively phosphorylated in Pttg(-/-) cells, a modification likely serving as a compensatory mechanism for Pttg deletion. The results indicate that Pttg deletion reduces BMSC proliferation, renders cells more sensitive to hypoxia, and enhances senescent features, thus pointing to a role for Pttg in the maintenance and proliferation of BMSCs.
引用
收藏
页码:C1082 / C1092
页数:11
相关论文
共 50 条
  • [31] Tilianin Promotes the Proliferation and Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells
    Xue, Zhixing
    Yang, Jin
    Yu, Panfeng
    CURRENT TOPICS IN NUTRACEUTICAL RESEARCH, 2022, 20 (02) : 259 - 264
  • [32] Identification of c-myc as a down-stream target for pituitary tumor-transforming gene
    Pei, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (11) : 8484 - 8491
  • [33] Gene expression during the differentiation of bone marrow stem cells into cardiomyocytes
    Li, Xiaohong
    Yu, Xiyong
    Shan, Zhixin
    Lin, Qiuxiong
    Zhong, Jiuchang
    Fu, Yongheng
    Huang, Wei
    Yang, Min
    Lin, Shuguang
    CELL RESEARCH, 2008, 18 (Suppl 1) : S52 - S52
  • [34] Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer
    Xu, Mi-die
    Dong, Lei
    Qi, Peng
    Weng, Wei-wei
    Shen, Xiao-han
    Ni, Shu-juan
    Huang, Dan
    Tan, Cong
    Sheng, Wei-qi
    Zhou, Xiao-yan
    Du, Xiang
    GASTRIC CANCER, 2016, 19 (01) : 107 - 115
  • [35] Gene expression during the differentiation of bone marrow stem cells into cardiomyocytes
    Xiaohong Li
    Xiyong Yu
    Zhixin Shan
    Qiuxiong Lin
    Jiuchang Zhong
    Yongheng Fu
    Wei Huang
    Min Yang
    Shuguang Lin
    Cell Research, 2008, 18 : S52 - S52
  • [36] Prognostic significance of human pituitary tumor-transforming gene immunohistochemical expression in differentiated thyroid cancer
    Sáez, C
    Martínez-Brocca, MA
    Castilla, C
    Soto, A
    Navarro, E
    Tortolero, M
    Pintor-Toro, JA
    Japón, MA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (04): : 1404 - 1409
  • [37] Neuronal differentiation of bone marrow-derived stromal stem cells involves suppression of discordant phenotypes through gene silencing
    Egusa, H
    Schweizer, FE
    Wang, CC
    Matsuka, Y
    Nishimura, I
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (25) : 23691 - 23697
  • [38] Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer
    Mi-die Xu
    Lei Dong
    Peng Qi
    Wei-wei Weng
    Xiao-han Shen
    Shu-juan Ni
    Dan Huang
    Cong Tan
    Wei-qi Sheng
    Xiao-yan Zhou
    Xiang Du
    Gastric Cancer, 2016, 19 : 107 - 115
  • [39] Pituitary tumor-transforming gene expression is a prognostic marker for tumor recurrence in squamous cell carcinoma of the head and neck
    Christine Solbach
    Marc Roller
    Frank Eckerdt
    Silke Peters
    Rainald Knecht
    BMC Cancer, 6
  • [40] Phosphatase and tensin homologue and pituitary tumor-transforming gene in pituitary adenomas. Clinical-pathologic and immunohistochemical analysis
    Lilia Tena-Suck, Martha
    Ortiz-Plata, Alma
    Astudillo de la Vega, Horacio
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2008, 12 (04) : 275 - 282